On Tuesday, GT Biopharma Inc (NASDAQ: GTBP) was 4.02% up from the session before settling in for the closing price of $0.77. A 52-week range for GTBP has been $0.54 – $4.10.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 54.16%. When this article was written, the company’s average yearly earnings per share was at 76.08%. With a float of $9.26 million, this company’s outstanding shares have now reached $10.64 million.
The extent of productivity of a business whose workforce counts for 1 workers is very important to gauge.
GT Biopharma Inc (GTBP) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward GT Biopharma Inc stocks. The insider ownership of GT Biopharma Inc is 12.92%, while institutional ownership is 4.93%.
GT Biopharma Inc (GTBP) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -1.66 earnings per share (EPS) during the time that was less than consensus figure (set at -1.55) by -0.11.
According to the Wall Street analysts, stocks earnings will be around 76.08% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 56.28% during the next five years compared to 54.16% growth over the previous five years of trading.
GT Biopharma Inc (NASDAQ: GTBP) Trading Performance Indicators
You can see what GT Biopharma Inc (GTBP) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.39, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.70 in one year’s time.
Technical Analysis of GT Biopharma Inc (GTBP)
The latest stats from [GT Biopharma Inc, GTBP] show that its last 5-days average volume of 2.88 million was superior to 0.81 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 84.51%.
During the past 100 days, GT Biopharma Inc’s (GTBP) raw stochastic average was set at 19.63%, which indicates a significant decrease from 89.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0623 in the past 14 days, which was lower than the 0.0971 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6925, while its 200-day Moving Average is $1.6651. Now, the first resistance to watch is $0.8287. This is followed by the second major resistance level at $0.8523. The third major resistance level sits at $0.8747. If the price goes on to break the first support level at $0.7827, it is likely to go to the next support level at $0.7603. The third support level lies at $0.7367 if the price breaches the second support level.
GT Biopharma Inc (NASDAQ: GTBP) Key Stats
There are 10,636K outstanding shares of the company, which has a market capitalization of 8.56 million. As of now, sales total 0 K while income totals -13,160 K. Its latest quarter income was 0 K while its last quarter net income were -3,110 K.
